Abstract
We conducted a case-control study in five general hospitals in the region of Antwerp, studying 161 patients (102 men, 59 women) and hospital control subjects matched for age and sex to explore the relation between drug use and upper gastrointestinal bleeding from 'erosive lesions' (peptic oesophagitis, gastric erosions, gastric ulcer(s), or duodenal ulcer(s]. There was a highly significant difference between cases and control subjects in the use of non-steroidal anti-inflammatory drugs (NSAIDs, excluding aspirin) (odds ratio 7.4, p less than 0.001; 95% confidence interval odds ratio 3.7 to 14.7). There also was a significant difference in the use of aspirin (odds ratio 2.2, p = 0.025; 95% CI odds ratio 1.3 to 4.0) and a highly significant difference regarding the presence of antecedents of peptic ulcer disease (odds ratio 5.5, p less than 0.001; 95% CI odds ratio 3.2 to 9.6). There was no significant difference in the use of other drugs, paracetamol and corticosteroids in particular, nor in the use of alcohol or tobacco. The patient group using NSAIDs was older, had more women, and had a higher mortality than the group not using NSAIDs. Among patients with bleeding gastric or duodenal ulcer(s), NSAID users were not more or less likely to have had symptoms of peptic ulcer disease, and had no higher frequency of multiple gastric or duodenal ulcers. The attributable risk for NSAID use was 0.30 (95% CI 0.23 to 0.37) and for aspirin use 0.14 (95% CI 0.08 to 0.20).
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armstrong C. P., Blower A. L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987 May;28(5):527–532. doi: 10.1136/gut.28.5.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bartle W. R., Gupta A. K., Lazor J. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study. Arch Intern Med. 1986 Dec;146(12):2365–2367. [PubMed] [Google Scholar]
- Bianchi Porro G., Pace F. Ulcerogenic drugs and upper gastrointestinal bleeding. Baillieres Clin Gastroenterol. 1988 Apr;2(2):309–327. doi: 10.1016/0950-3528(88)90006-1. [DOI] [PubMed] [Google Scholar]
- Biour M., Blanquart A., Moore N., Grange J. D., Amiot X., Levy V. G., Darnis F., Cheymol G. Incidence of NSAID-related, severe gastrointestinal bleeding. Lancet. 1987 Aug 8;2(8554):340–341. doi: 10.1016/s0140-6736(87)90936-6. [DOI] [PubMed] [Google Scholar]
- Carson J. L., Strom B. L., Soper K. A., West S. L., Morse M. L. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med. 1987 Jan;147(1):85–88. [PubMed] [Google Scholar]
- Coggon D., Langman M. J., Spiegelhalter D. Aspirin, paracetamol, and haematemesis and melaena. Gut. 1982 Apr;23(4):340–344. doi: 10.1136/gut.23.4.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conn H. O., Poynard T. Adrenocorticosteroid administration and peptic ulcer: a critical analysis. J Chronic Dis. 1985;38(6):457–468. doi: 10.1016/0021-9681(85)90028-1. [DOI] [PubMed] [Google Scholar]
- Duggan J. M., Dobson A. J., Johnson H., Fahey P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut. 1986 Aug;27(8):929–933. doi: 10.1136/gut.27.8.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duhamel C., Czernichow P., Dechelotte P., Ducrotte P., Lerebours E., Colin R. Hémorragies digestives hautes sous anti-inflammatories. Gastroenterol Clin Biol. 1989 Mar;13(3):239–244. [PubMed] [Google Scholar]
- Faulkner G., Prichard P., Somerville K., Langman M. J. Aspirin and bleeding peptic ulcers in the elderly. BMJ. 1988 Nov 19;297(6659):1311–1313. doi: 10.1136/bmj.297.6659.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heller S. R., Fellows I. W., Ogilvie A. L., Atkinson M. Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. Br Med J (Clin Res Ed) 1982 Jul 17;285(6336):167–168. doi: 10.1136/bmj.285.6336.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henry D. A., Johnston A., Dobson A., Duggan J. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. Br Med J (Clin Res Ed) 1987 Nov 14;295(6608):1227–1229. doi: 10.1136/bmj.295.6608.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Langman M. J. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):640–646. doi: 10.1016/s0016-5085(89)80060-5. [DOI] [PubMed] [Google Scholar]
- Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med. 1974 May 23;290(21):1158–1162. doi: 10.1056/NEJM197405232902102. [DOI] [PubMed] [Google Scholar]
- Levy M., Miller D. R., Kaufman D. W., Siskind V., Schwingl P., Rosenberg L., Strom B., Shapiro S. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med. 1988 Feb;148(2):281–285. doi: 10.1001/archinte.148.2.281. [DOI] [PubMed] [Google Scholar]
- Soll A. H. Pathogenesis of peptic ulcer and implications for therapy. N Engl J Med. 1990 Mar 29;322(13):909–916. doi: 10.1056/NEJM199003293221307. [DOI] [PubMed] [Google Scholar]
- Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]
- de Boer S. Y., van Berge Henegouwen G. P., Kluitman E. M. Niet-steroïde anti-inflammatoire geneesmiddelen en bloedingen uit maag- en duodenumulcera. Ned Tijdschr Geneeskd. 1988 Jan 23;132(4):160–163. [PubMed] [Google Scholar]
